Reaction equation
[I:1][C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][CH:10]=1)[C:5]([OH:7])=O.[F:11][C:12]1[CH:13]=[C:14]([CH:16]=[CH:17][C:18]=1[O:19][C:20]([F:23])([F:22])[F:21])[NH2:15]>>[F:11][C:12]1[CH:13]=[C:14]([NH:15][C:5](=[O:7])[C:4]2[CH:8]=[CH:9][CH:10]=[C:2]([I:1])[CH:3]=2)[CH:16]=[CH:17][C:18]=1[O:19][C:20]([F:22])([F:23])[F:21]Participants
3
Procedure
The title compound was prepared in an analogous fashion to that described in Stage 30.1 using 3-iodobenzoic acid and 3-fluoro-4-(trifluoromethoxy)aniline to afford the title compound as a white solid. UPLC-MS (Condition 1) tR=3.39 min, m/z=425.9 [M+H]+, m/z=423.9 [M−H]−; 1H-NMR (400 MHz, DMSO-d6) δ ppm 7.32-7.40 (m, 1H) 7.54-7.62 (m, 1H) 7.64 (dd, 1H) 7.93-8.01 (m, 3H) 8.29 (s, 1H) 10.64 (s, 1H).
Workup
- customThe title compound was prepared in an analogous fashion to
Sources & evidence
- ORD record
- ord-213804908a0c44128c284fa57ce5542d
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09315489B2
Linked notes
Loading…